Evidence map›Paper›PMID 23376452›Full record

ArticleGene2013

Significant differences in genotoxicity induced by retrovirus integration in human T cells and induced pluripotent stem cells.

Weiyan Zheng, Yingjia Wang, Tammy Chang, He Huang, Jiing-Kuan Yee

Abstract read
In one paragraph

Article in Gene, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Weiyan ZhengBone Marrow Transplantation Center, Department of Hematology, The First Affiliated Hospital, Zhejiang University, Hangzhou, China.
Yingjia Wang
Tammy Chang
He Huang
Jiing-Kuan Yee
First Affiliated Hospital Zhejiang University · CNCity Of Hope National Medical Center · US

Funding

Suplement to Safety and Efficacy of AIDS Gene Therapy in MonkeysP01AI061839 · NIAID · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI ZAIA, JOHN A · 2004 to 2007
$7.1M
NIAID NIH HHS AI061839NIAID NIH HHS P01 AI061839
6 · The paper itself

Abstract

Retrovirus is frequently used in the genetic modification of mammalian cells and the establishment of induced pluripotent stem cells (iPSCs) via cell reprogramming. Vector-induced genotoxicity could induce profound effect on the physiology and function of these stem cells and their differentiated progeny. We analyzed retrovirus-induced genotoxicity in somatic cell Jurkat and two iPSC lines. In Jurkat cells, retrovirus frequently activated host gene expression and gene activation was not dependent on the distance between the integration site and the transcription start site of the host gene. In contrast, retrovirus frequently down-regulated host gene expression in iPSCs, possibly due to the action of chromatin silencing that spreads from the provirus to the nearby host gene promoter. Our data raises the issue that some of the phenotypic variability observed among iPSC clones derived from the same parental cell line may be caused by retrovirus-induced gene expression changes rather than by the reprogramming process itself. It also underscores the importance of characterizing retrovirus integration and carrying out risk assessment of iPSCs before they can be applied in basic research and clinics.

Indexed as

DNA DamageCell DifferentiationCloning, MolecularDown-RegulationGenetic VectorsHEK293 CellsHumansInduced Pluripotent Stem CellsJurkat CellsMutagenesis, InsertionalRetroviridaeT-LymphocytesTransfection

Identifiers

PMID23376452
PMCPMC3605218
OpenAlexW2084565268

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.